It’s Time to
ACT
IDENTIFY
CARE
MOVE FOWARD
WEEKS
Time Matters
A 10-year countdown
to HCV elimination
What is the situation today?
[80,000]
Undiagnosed Saudi individuals with active HCV1,2
[2.5%]
Estimated new infections
per year1,2
What could be done to help?
How To Screen HCV?
![images](img/book2/Cover-Book1.png)
Screening Assesment Guide
View
![images](img/book2/Cover-Book2.jpg)
Guidance to HCV Screening
View
Pre-Treatment Guide
![images](img/book2/Cover-Book3.jpg)
Pre-Treatment Assessment Guide
View
![images](img/book2/Cover-Book4.jpg)
HBV Reactivation Guide
View
![images](img/book2/Cover-Book5.jpg)
Pre-Treatment Lab Assessments
View
![images](img/book2/Cover-Book6.jpg)
Referral and pre treatment assessment
View
On Treatment Monitoring Guide
![images](img/book2/Cover-Book7.jpg)
On Treatment Monitoring Guide
View
![images](img/book2/Cover-Book8.jpg)
Guidance to simplified treatment
View
Post Treatment Assessment Guide
![images](img/book2/Cover-Book9.jpg)
Post Treatment Assessment Guide
View
Extra-Hepatic Manifestation Guide
![images](img/book2/Cover-Book10.jpg)
Extra-Hepatic Manifestation Guide
View
What We Aim to Achieve in 2030
[~90%]
Reduction in
HCV new cases1,2
[~3000]
Deaths
to be avoided1,2
References:
1. Aljumah AA, Abaalkhail F, et al. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Saudi J Gastroenterol 2016;22:269‑81 2. Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Medical Journal. 2018;39(8):842-845. 3. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. 4. Douglass CH, et al. BMC Med. 2018;16:175. doi:10.1186/ s12916-018-1162-z 5. Reau N, et al. Hepatol Commun. 2017;1:439–452. doi:10.1002/hep4.1049 6. Vietri J, et al. BMC Gastroenterol. 2013;13:16. doi:10.1186/1471-230X-13-16 7. Ghany MG, Strader DB, ThoHowlader N, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.mas DL, et al. Hepatology. 2009;49(4):1335–1374. EMCDDA Insights. Hepatitis C among drug users in Europe. 2016;
Approval Code: ABBV-SA-00012-MC
Copyright © 2021 AbbVie Inc. North Chicago, Illinois, U.S.A.